John J. Kim

John J. Kim

Auto-generated profile, based on publicly available information

John J. Kim

Division of Gastroenterology and Hepatology, Loma Linda University Health, Loma Linda, California, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
YZYawen Zhang
Yawen Zhang
MCMengsha Cen
Mengsha Cen
MHMengjia Hu
Mengjia Hu
LDLijun Du
Lijun Du
WHWeiling Hu
Weiling Hu
NDNing Dai
Ning Dai
INTRODUCTION: The prevalence and shedding of fecal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA indicate coronavirus disease 2019 (COVID-19) infection in the gastrointestinal (GI) tract and likely infectivity. We performed a systemic review and meta-analysis to evaluate the prevalence and the duration of shedding of fecal RNA in patients with COVID-19 infection. METHODS: PubMed, Embase, Web of Science, and Chinese databases Chinese National Knowledge Infrastructure and Wanfang Data up to June 2020 were searched for studies evaluating fecal SARS-CoV-2 RNA, including anal and rectal samples, in patients with confirmed COVID-19 infection. The pooled prevalence of fecal RNA in patients with detectable respiratory RNA was estimated. The days of shedding and days to loss of fecal and respiratory RNA from presentation were compared. RESULTS: Thirty-five studies (N = 1,636) met criteria. The pooled prevalence of fecal RNA in COVID-19 patients was 43% (95% confidence interval [CI] 34%–52%). Higher proportion of patients with GI symptoms (52.4% vs 25.9%, odds ratio = 2.4, 95% CI 1.2–4.7) compared with no GI symptoms, specifically diarrhea (51.6% vs 24.0%, odds ratio = 3.0, 95% CI 1.9–4.8), had detectable fecal RNA. After loss of respiratory RNA, 27% (95% CI 15%–44%) of the patients had persistent shedding of fecal RNA. Days of RNA shedding in the feces were longer than respiratory samples (21.8 vs 14.7 days, mean difference = 7.1 days, 95% CI 1.2–13.0). Furthermore, days to loss of fecal RNA lagged respiratory RNA by a mean of 4.8 days (95% CI 2.2–7.5). DISCUSSION: Fecal SARS-CoV-2 RNA is commonly detected in COVID-19 patients with a 3-fold increased risk with diarrhea. Shedding of fecal RNA lasted more than 3 weeks after presentation and a week after last detectable respiratory RNA.

2 February 2018 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
LDL. Du
L. Du
BCB. Chen
B. Chen
JKJ. J. Kim
J. J. Kim
XCX. Chen
X. Chen
NDNing Dai
Ning Dai

22 May 2015 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
FLF. Lee
F. Lee
EOE. Ohanian
E. Ohanian
JRJ. Rheem
J. Rheem
LLL. Laine
L. Laine
KCK. Che
K. Che
JKJ. J. Kim
J. J. Kim
Background Predictors of organ failure and the impact of early endoscopic retrograde cholangiopancreatography (ERCP) on outcomes in patients with acute cholangitis are unclear. Aim To identify factors associated with persistent organ failure and assess the impact of early ERCP on outcomes in hospitalised patients with cholangitis. Methods Consecutive hospitalised patients who received ERCP at two centres for cholangitis from 4/2005–3/2013 were retrospectively reviewed. Delayed ERCP was defined as ERCP ≥48 h after hospitalisation. Primary outcome was persistent organ failure at >48 h after hospitalisation (≥1.5 times rise in creatinine levels from baseline values to ≥1.5 mg/dL or need for dialysis, mechanical ventilation and/or hypotension requiring vasopressor). Results 203 patients (mean age 59 ± 19 years) had ERCP for cholangitis: 115 with choledocholithiasis, 48 with other benign obstructions and 40 with malignant strictures. Forty‐five (22%) patients had persistent organ failure at >48 h and 11 (5%) died. On multivariate analysis, Charlson Comorbidity Index >2 (OR = 4.6, 95% CI = 1.5–13.8), systemic inflammatory response syndrome (SIRS; OR = 3.2, 95% CI = 1.1–9.8), hypoalbuminemia (OR = 3.3, 95% CI = 1.4–7.9), bacteremia (OR = 2.8, 95% CI 1.3–6.2) and delayed ERCP(OR = 3.1, 95% CI: 1.4–7.0) were associated with persistent organ failure. Every 1‐day delay in ERCP was associated with a 17% (95% CI = 5–29%) relative risk increase in persistent organ failure after adjusting for significant factors. Conclusions Delay in ERCP beyond 48 h was associated with persistent organ failure in hospitalised patients with acute cholangitis. Other factors included increased comorbidities, SIRS, hypoalbuminemia and bacteremia. Early ERCP performed within 48 h after presentation in patients with cholangitis may improve outcomes.

1 March 2020 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
LDLijun Du
Lijun Du
MCMengsha Cen
Mengsha Cen
XZXia Zheng
Xia Zheng
LLLiang Luo
Liang Luo
ASAli Siddiqui
Ali Siddiqui
JKJohn J. Kim
John J. Kim
OBJECTIVES: Although early biliary drainage improves outcomes in patients with acute cholangitis, the optimal time to perform endoscopic retrograde cholangiopancreatography (ERCP) is controversial. Our aim was to evaluate the impact of timing of ERCP on mortality in hospitalized patients with acute cholangitis. METHODS: We searched PubMed, EMBASE, and The Cochrane Library (until February 2019) for studies evaluating the impact of timing of ERCP (<24, <48, and <72 hours from hospitalization) on outcomes in patients with acute cholangitis. The primary outcome was in-hospital mortality. RESULTS: Fourteen observational studies, including 84,063 patients (mean age = 66 ± 18), met the study criteria. The overall pooled in-hospital mortality with acute cholangitis was 1.9% (95% confidence interval [CI] 1.8%–7.6%), which increased to 4.3% (95% CI 1.8%–8.7%) when administrative database studies were excluded. In 9 studies, ERCP performed <24 compared with ≥24 hours decreased in-hospital mortality (odds ratio [OR] = 0.81, 95% CI 0.73–0.90; I 2 = 0%). In 8 studies, ERCP performed <48 compared with ≥48 hours decreased in-hospital mortality (OR = 0.57, 95% CI 0.51–0.63; I 2 = 0%). In 4 studies, ERCP performed <72 compared with ≥72 hours decreased in-hospital mortality (OR = 0.32, 95% CI 0.15–0.68; I 2 = 0%). Furthermore, hospital stay was reduced in patients receiving ERCP <24 compared with ≥24 hours (mean difference [MD] = 3.2 days, 95% CI 2.3–4.1; I 2 = 78%), <48 compared with ≥48 hours (MD = 3.6 days, 95% CI 2.1–5.1; I 2 = 98%), and <72 compared with ≥72 hours (MD = 4.1 days, 95% CI 0.9–7.3; I 2 = 63%). DISCUSSION: In observational studies, earlier ERCP performed in patients with acute cholangitis, even urgently performed <24 hours from presentation, was associated with reduced mortality. A randomized trial evaluating the impact of urgent ERCP on outcomes is needed.

11 April 2018 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
YLY. Long
Y. Long
LDL. Du
L. Du
JKJ. J. Kim
J. J. Kim
BCB. Chen
B. Chen
YZY. Zhu
Y. Zhu
NDNing Dai
Ning Dai

1 August 2021 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
NLNe Lin
Ne Lin
TYTao Yu
Tao Yu
WZWenfang Zheng
Wenfang Zheng
HHHuiyi Hu
Huiyi Hu
LXLijuan Xiang
Lijuan Xiang
JSJianmin Si
Jianmin Si
INTRODUCTION: Patients with atrophic gastritis (AG) or gastric intestinal metaplasia (GIM) have elevated risk of gastric adenocarcinoma. Endoscopic screening and surveillance have been implemented in high incidence countries. The study aimed to evaluate the accuracy of a deep convolutional neural network (CNN) for simultaneous recognition of AG and GIM. METHODS: Archived endoscopic white light images with corresponding gastric biopsies were collected from 14 hospitals located in different regions of China. Corresponding images by anatomic sites containing AG, GIM, and chronic non-AG were categorized using pathology reports. The participants were randomly assigned (8:1:1) to the training cohort for developing the CNN model (TResNet), the validation cohort for fine-tuning, and the test cohort for evaluating the diagnostic accuracy. The area under the curve (AUC), sensitivity, specificity, and accuracy with 95% confidence interval (CI) were calculated. RESULTS: A total of 7,037 endoscopic images from 2,741 participants were used to develop the CNN for recognition of AG and/or GIM. The AUC for recognizing AG was 0.98 (95% CI 0.97–0.99) with sensitivity, specificity, and accuracy of 96.2% (95% CI 94.2%–97.6%), 96.4% (95% CI 94.8%–97.9%), and 96.4% (95% CI 94.4%–97.8%), respectively. The AUC for recognizing GIM was 0.99 (95% CI 0.98–1.00) with sensitivity, specificity, and accuracy of 97.9% (95% CI 96.2%–98.9%), 97.5% (95% CI 95.8%–98.6%), and 97.6% (95% CI 95.8%–98.6%), respectively. DISCUSSION: CNN using endoscopic white light images achieved high diagnostic accuracy in recognizing AG and GIM.